台股 » 個股 » 訊聯 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

訊聯

(1784)
可現股當沖
  • 股價
    69.4
  • 漲跌
    ▲6.3
  • 漲幅
    +9.98%
  • 成交量
    1,200
  • 產業
    上櫃 生技醫療類股
  • 105人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
訊聯 (1784)籌碼相關-日茂-南投 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

日茂-南投 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/04/2400.00263.6563.10-2291-0.69%
2024/04/23264.7000.0064.1022880.69%
2023/11/1300.00158.6058.10-1405-0.25%
2023/11/09161.2000.0059.6014180.24%
2023/08/1700.00268.1068.00-21,251-0.16%
2023/07/1700.00173.5074.00-12,068-0.05%
2023/07/14167.7000.0067.8012,0530.05%
2023/07/0700.00167.2066.70-12,192-0.05%
2023/06/27165.4000.0065.2012,2530.04%
2023/05/2400.00466.3563.90-42,122-0.19%
2023/05/1200.00166.3065.00-12,045-0.05%
2023/05/04369.50169.1069.5021,7180.12%
2023/05/03363.9700.0063.2031,6280.18%
2023/04/27157.6000.0058.0011,4740.07%
2023/04/24158.8000.0059.4011,3210.08%
2023/04/1300.00553.0052.50-5931-0.54%
2023/03/2800.00146.6046.30-1688-0.15%
2023/03/0800.00144.8545.25-1727-0.14%
2023/03/0700.00145.6045.10-1777-0.13%
2023/02/17143.7000.0043.9016800.15%
2023/02/16245.7500.0045.9526190.32%
2023/02/1300.00146.9046.35-1474-0.21%
2022/12/26144.0000.0044.2012880.35%
2022/07/0700.00137.6039.75-1206-0.48%
2022/06/28142.5500.0042.0011930.52%
2022/04/1400.00138.3539.05-1114-0.87%
2021/11/17143.80145.8043.7004420.00%
2021/11/11141.5000.0041.2513840.26%
2021/08/09546.4000.0046.0551,1430.44%
2021/06/0700.00445.4844.95-41,070-0.37%
2021/06/04445.1000.0044.8049950.40%
2021/06/0300.001042.9542.60-10951-1.05%
2021/06/021042.20141.4041.9099400.96%
2021/06/01140.30140.4041.4509620.00%
2021/04/1200.00147.7045.50-1520-0.19%
2021/04/09144.70144.5043.5004120.00%
2021/04/08141.201741.2641.15-16353-4.53%
2021/04/07742.3000.0042.1073442.03%
2021/04/0600.002040.2340.35-20311-6.41%
2021/03/222040.2800.0039.70202617.65%
2021/03/1100.001038.3738.35-10255-3.91%
2021/03/052039.8500.0038.90203166.32%
2021/01/25136.4000.0036.8012980.33%
2021/01/1400.00138.4038.30-1291-0.34%
2021/01/1100.00239.3539.10-2286-0.70%
2020/12/2500.00140.6540.70-1286-0.35%
2020/11/1300.00537.0337.35-5356-1.40%
2020/10/1900.00238.4038.40-2762-0.26%
2020/09/3000.00239.0039.00-21,901-0.11%
2020/07/21252.9500.0052.8022,7850.07%
2020/07/1700.00146.6044.95-12,595-0.04%
2020/07/15150.10151.7048.8002,5270.00%
2020/07/14149.0000.0049.5012,4470.04%
2020/07/13555.0000.0052.0052,3780.21%
2020/07/10255.50454.3855.60-22,182-0.09%
2020/07/0700.00342.1041.90-31,840-0.16%
2020/06/0500.00738.1938.20-71,381-0.51%
2020/05/2900.00238.9038.80-21,394-0.14%
2020/05/2100.00138.5038.40-11,184-0.08%
2020/05/2000.00538.1038.00-51,177-0.42%
2020/05/18541.4500.0039.5051,1830.42%
2020/05/1300.00340.7040.25-31,099-0.27%
2020/05/11742.0400.0039.0571,0120.69%
2020/05/07541.0800.0041.0558820.57%
2020/04/2800.00233.2032.80-2678-0.29%
2020/04/27233.3500.0033.1526850.29%
2020/04/21132.0000.0031.9516140.16%
2020/03/2700.00127.5027.35-1534-0.19%
2020/03/25126.4000.0026.2015360.19%
2020/03/1700.00326.1526.40-3537-0.56%
2020/02/1800.00137.6037.40-1600-0.17%
2020/02/11136.7000.0036.7016350.16%
2020/02/0500.00138.0038.00-1679-0.15%
2019/12/11142.5000.0042.8011,0720.09%
2019/11/28645.78645.3645.4001,2880.00%
2019/11/21544.10543.9043.8001,2230.00%
2019/11/1400.00142.0042.00-11,224-0.08%
2019/11/0800.00546.2045.70-51,288-0.39%
2019/11/07547.4000.0046.0051,3000.38%
2019/09/23146.5500.0046.1013,2300.03%
2019/09/1000.00147.8047.70-13,142-0.03%
2019/09/05144.0000.0044.3013,0420.03%
2019/09/0200.00543.9043.85-53,046-0.16%
2019/08/29543.2500.0043.3553,1630.16%
2019/08/2200.00544.7644.70-53,209-0.16%
2019/08/19545.3000.0045.1553,2050.16%
2019/08/0800.00143.8043.30-13,185-0.03%
2019/08/05142.7000.0042.2513,1500.03%
2019/08/02145.1000.0044.9013,1260.03%
2019/07/30146.0000.0046.5013,0650.03%
2019/07/29149.6000.0049.6013,0400.03%
2019/07/26151.70551.6051.60-43,029-0.13%
2019/07/25452.60152.6052.2032,9890.10%
2019/07/22254.1000.0053.8022,8550.07%
2019/07/19652.2700.0053.9062,7530.22%
2019/07/1800.00251.3052.40-22,641-0.08%
2019/07/17247.5000.0047.6522,4600.08%
2019/07/16648.50647.6947.5002,4390.00%
2019/07/15147.0000.0047.1012,3650.04%
2019/07/1200.00247.5547.85-22,353-0.08%
2019/07/05147.1500.0047.0012,0910.05%
2019/07/04143.85145.1546.8501,9940.00%
2019/07/032645.852044.6044.3061,8780.32%
2019/07/0200.00344.1044.10-31,636-0.18%
2019/06/1800.00538.6738.25-51,409-0.35%
2019/06/171039.65539.2539.1551,4130.35%
2019/06/04538.50539.1539.0501,3330.00%
2019/05/3100.00537.1537.30-51,270-0.39%
2019/05/24437.9300.0037.6541,3220.30%
2019/05/2300.00437.8337.50-41,324-0.30%
2019/05/1600.00336.6836.65-31,509-0.20%
2019/05/15537.65537.2537.1001,6010.00%
2019/05/09137.0000.0037.1011,6220.06%
2019/05/07139.0000.0038.8511,6330.06%
2019/05/061139.97539.7039.0561,6390.37%
2019/04/16139.0500.0039.1011,8220.05%
2019/03/1300.001037.0537.40-101,689-0.59%
2019/03/1200.00537.0337.00-51,724-0.29%
2019/03/08537.7000.0037.5051,7200.29%
2019/03/071037.3000.0036.95101,7270.58%
2019/02/15139.1500.0038.8011,5120.07%
2019/02/1200.00135.0534.80-11,280-0.08%
2019/01/29133.2000.0033.0011,2300.08%
2019/01/1000.001934.4334.40-19929-2.04%
2019/01/0900.001432.6934.10-14924-1.51%
2019/01/0800.001031.8031.80-10785-1.27%
2019/01/071029.00228.5028.9587591.05%
2018/12/2500.001126.1026.00-11797-1.38%
2018/12/171626.8300.0027.20169201.74%
2018/12/131526.8000.0026.25151,0331.45%
2018/11/26425.84125.8526.1531,6990.18%
2018/11/1300.00224.3524.50-21,629-0.12%
2018/11/09124.8000.0024.2511,6230.06%
2018/10/22126.6500.0026.4011,5200.07%
2018/10/1600.00325.3025.30-31,385-0.22%
2018/09/1900.00632.9033.00-61,027-0.58%
2018/09/18633.7000.0034.0569270.65%
2018/09/111233.92932.0332.1036240.48%
2018/09/1000.002032.4032.75-20476-4.19%
2018/09/072029.8000.0029.80203565.61%
2018/07/1200.00126.8027.05-1142-0.70%
2018/07/10126.4000.0026.6011430.70%
2018/07/091027.75127.1026.8591426.31%
2018/06/29126.3000.0026.4511840.54%
2018/05/3100.00126.9027.00-1209-0.48%
2018/05/28126.3000.0026.3012040.49%
2018/05/2200.00126.9026.55-1191-0.52%
2018/05/09125.8000.0025.7012350.42%
2018/03/07426.5800.0026.4042031.96%
2018/01/1500.00127.3527.85-171-1.39%
訊聯細胞智藥攜手韓新創公司 搶攻外泌體商機Anue鉅亨-2023/11/27
〈訊聯展望〉看好基因定序健保商機 脊髓肌肉萎縮檢測滲透率上看90%Anue鉅亨-2023/08/09
訊聯 相關文章
訊聯 相關影音